|12 Months Ended|
Dec. 31, 2020
|Inventory Disclosure [Abstract]|
NOTE 8 – INVENTORY
At December 31, 2020 and 2019, inventory was comprised of the following:
SCHEDULE OF INVENTORY
The anticipated year-over-year increase of inventory is based on the Company’s implementation of its aforementioned Consolidation Plan whereby it is transitioning from a management and advisory firm in the cannabis space, to a cannabis licensee and direct owner of cannabis cultivation, manufacturing, and dispensary operations.
The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef